trial

Gamma Light and Sound Stimulation in Schizophrenia

NCTId NCT07342465
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 20 (estimated)
Sponsored by Massachusetts Institute of Technology
Primary completion 2027-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2026-04
Primary completion
2027-04
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
GENUS

Sponsors

Massachusetts Institute of TechnologyLead Sponsor
Mclean HospitalCollaborator

Investigators

1
Li-Huei Tsai, PhDPrincipal Investigator

Sites

1 total
Cambridge, United States

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2027-04
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
GENUS
drug
lead_sponsor
Massachusetts Institute of Technology
company
collaborator
Mclean Hospital
company
indication
Schizophrenia
indication
Schizophrenia Spectrum Disorders
indication
investigator
Li-Huei Tsai, PhD
person